Dr. Brunner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
Cincinnati, OH 45229Phone+1 513-636-4676Fax+1 513-636-5568
Summary
- Dr. Hermine Brunner is a pediatric rheumatologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. She received her medical degree from Ludwig Maximilian University of Munich Faculty of Medicine and has been in practice 29 years. She also speaks multiple languages, including German. She is experienced in pediatric rheumatology, clinical research, and drug development.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Rheumatology, 1999 - 2001
- University of ChicagoResidency, Pediatrics, 1994 - 1997
- Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989
- Ludwig Maximilian University of Munich Faculty of MedicineClass of 1987
Certifications & Licensure
- KY State Medical License 2021 - 2025
- OH State Medical License 2000 - 2025
- PA State Medical License 2001 - 2002
- IL State Medical License 1994 - 1997
- American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Triptorelin for Ovary Protection in Childhood Onset Lupus Start of enrollment: 2003 Jun 01
- Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus Start of enrollment: 2017 Aug 23
Publications & Presentations
PubMed
- 11 citationsMalignancy in Pediatric-onset Systemic Lupus Erythematosus.Sasha Bernatsky, Ann E. Clarke, Omid Zahedi Niaki, Jeremy A. Labrecque, Laura E. Schanberg
The Journal of Rheumatology. 2017-10-01 - 72 citationsTofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialNicolino Ruperto, Hermine I. Brunner, Olga Synoverska, Tracy V. Ting, Carlos Abud Mendoza
Lancet. 2021-11-09 - 269 citationsTransancestral mapping and genetic load in systemic lupus erythematosusCarl D. Langefeld, Hannah C. Ainsworth, Deborah S. Cunninghame Graham, Jennifer A. Kelly, Mary E. Comeau
Nature Communications. 2017-07-17
Journal Articles
- Discovery of SERPINA3 as a Candidate Urinary Biomarker of Lupus Nephritis ActivityMichael Bennett, Hermine I Brunner, Prasad Devarajan, Gaurav Gulati, Jessica L Turnier, Sherry Thornton, David Witte, Bruce Aronow, Rheumatology
- Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
Lectures
- Tocilizumab Significantly Reduces Flares in Polyarticular Juvenile Idiopathic Arthritis76th Annual Scienific Meeting, Washington, DC, USA
- Tocilizumab Significantly Reduces Flares in Polyarticular Juvenile Idiopathic ArthritisAmerican College of Rheumatology, 76th Annual Scienific Meeting, Washington, DC, USA
Press Mentions
- S100 Protein Levels Predict Abatacept Response in Juvenile Idiopathic ArthritisAugust 8th, 2024
- Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic DiseasesNovember 3rd, 2021
- Extensive Assessment Critical to Dispel 'Ambiguity' Mimics in Juvenile DermatomyositisAugust 6th, 2021
- Join now to see all
Grant Support
- Towards Measures Of Lupus Nephritis Activity &Damage For ChildrenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
- Improved Diagnostics &Advanced Magnetic Resonance Imaging For Pediatric NpsleNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
- Improved Diagnostics &Advanced Magnetic Resonance Imaging For Pediatric NpsleNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009
- Efficacy Measures For Pediatric Lupus StudiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
- Clinical Trial: Triptorelin For Ovary Protection In LupusNational Center For Research Resources2008
- Atherosclerosis Prevention In Pediatric Lupus Erythematosus (APPLE)National Center For Research Resources2006–2007
- Triptorelin For Ovary Protection In LupusNational Center For Research Resources2005–2007
- Long-Term Outcomes In Systemic Lupus ErythematosusNational Center For Research Resources2005–2007
- Triptorelin For Ovary Protection In Childhood LipusFood And Drug Administration2005–2007
- Meaningful Outcome Measures For Pediatrc Lupus TrialsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2006
- Guidelines For Steroids In Children With LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2005
- Meaningful Outcome Measures For Pediatric Lupus TrialsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
- Gonadal Function In Childhood Onset SLENational Center For Research Resources2004
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: